About Joseph Dunham
Form D filings for SeqOnce BioSciences from 2018 to 2024 list Joseph Dunham as director.
Joseph Dunham first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Joseph Dunham in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Joseph Dunham works with at each company, as listed on that company's latest Form D.
SeqOnce BioSciences, Inc. · Form D, Nov 5, 2024
CA
Christopher Angermayer
Chief Executive Officer and director